Understanding Patient Goals and Risk Factors When Determining Therapy for Newly Diagnosed and Recurrent/Relapsed CLL

Date: September 21, 2023

Time: 03:00PM - 04:00PM

You must be registered to participate!


Join Sara M. Tinsley-Vance, PhD, APRN, AOCN, of Moffitt Cancer Center, while she discusses the AP role in best practices for managing CLL. The therapeutic landscape for CLL management has changed rapidly the past few years, making it difficult to identify the most appropriate treatment for each patient. In addition, side effect profiles vary by agent, and each patient may have unique goals regarding quality of life, time spent on treatment, and side effect management. Sara will discuss three complex cases, ranging from recently diagnosed disease to relapsed/refractory disease.

Access the cases and polling questions here